openPR Logo
Press release

Neuropathic Pain Market Expansion is Backed by Diabetes Prevalence & Novel Drug Approvals- Forecast By 2033 | Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company. among others

07-10-2025 09:09 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Neuropathic Pain Market

Neuropathic Pain Market

Neuropathic Pain Market reached US$ 8.44 Billion in 2024 and is expected to reach US$ 18.45 Billion by 2033, growing at a CAGR of 8.9 % during the forecast period 2025-2033.

The latest Neuropathic Pain Market Report by DataM Intelligence offers a clear analysis of global trends, market size, key players, and growth drivers. Covering emerging technologies, evolving care models, and regulatory insights, it provides strategic intelligence to help stakeholders navigate the dynamic healthcare landscape through 2025-2033

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access):
https://www.datamintelligence.com/download-sample/neuropathic-pain-market?ophp

Neuropathic pain results from nerve damage or dysfunction and manifests as burning, tingling, or shooting sensations. With rising cases linked to diabetes, cancer treatment, and spinal injuries, the market is growing steadily, supported by advancements in anticonvulsants, antidepressants, and targeted pain therapies.

Neuropathic Pain Market Competitors Overview:

The major global players in the neuropathic pain market include Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal, Teva Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd., among others.

Important Industry Updates of 2024 and 2025:

✅ In November 2024, Grünenthal announced that its U.S. subsidiary, Averitas Pharma, Inc., had completed recruitment for the Phase III clinical trial known as AV001. This trial is designed to evaluate the efficacy, safety, and tolerability of QUTENZA (capsaicin) 8% topical system specifically for treating post-surgical neuropathic pain (PSNP). If the trial results are positive, they could support an extension of QUTENZA's label in the U.S. market.

Neuropathic Pain Market Segments Overview:

∎ By Type (Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Post-Herpetic Neuralgia, Trigeminal Neuralgia, Spinal Stenosis, Others)
∎ By Treatment Type (Drug Class, Devices)
∎ By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/neuropathic-pain-market?ophp

Methodology and Scope:

This Neuropathic Pain Market report is developed using a robust research methodology that combines primary interviews, insights from industry experts, and verified secondary sources such as company filings, trade journals, and trusted databases. It follows a bottom-up and top-down approach to ensure data accuracy through triangulation. The scope of the report covers current market trends, growth potential, and strategic developments across global and regional markets.

Regional Overview for Neuropathic Pain Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Looking For Exclusive Full Report? Get it here: https://www.datamintelligence.com/buy-now-page?report=neuropathic-pain-market?ophp

The Report Includes:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.

People Also Ask:

➤ What are the global sales, production, import, and export trends in the Neuropathic Pain market?
➤ Who are the top manufacturers, and what are their output, pricing, and revenue figures?
➤ What key opportunities and challenges do vendors face in this market?
➤ Which product types, applications, or end-users are driving growth and holding market share?
➤ What are the main growth drivers and restraints affecting the Neuropathic Pain market?
Unlock 360° Market Intelligence with DataM Subscription Services:
https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Market Expansion is Backed by Diabetes Prevalence & Novel Drug Approvals- Forecast By 2033 | Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company. among others here

News-ID: 4098818 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Digital Oilfield Market to Reach 7.1% CAGR by 2032; North America Leads with 40% Share | Key Players: Schlumberger, Halliburton, Baker Hughes, Emerson, Rockwell Automation
Digital Oilfield Market to Reach 7.1% CAGR by 2032; North America Leads with 40% …
Market Overview The Global Digital Oilfield Market is witnessing significant growth, with a CAGR of 7.1% during the forecast period. The market is driven by increasing adoption of advanced software and data analytics in oil and gas operations, enabling operators to enhance field productivity, reduce operational costs, and optimize decision-making processes. Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):-https://www.datamintelligence.com/download-sample/global-digital-oilfield-market?Juli A digital oilfield leverages technology to simulate
Hydropower Market to Reach US$ 348.2 Billion by 2030; Asia-Pacific Leads with 45% Share | Key Players: China Three Gorges Corporation, Electricite de France, Hydro-Quebec, Duke Energy
Hydropower Market to Reach US$ 348.2 Billion by 2030; Asia-Pacific Leads with 45 …
Market Overview The global hydropower market reached US$ 244.1 billion in 2022 and is projected to reach US$ 348.2 billion by 2030, growing at a CAGR of 4.8% during 2024-2031. Hydropower continues to be a key renewable energy source worldwide, driven by innovations in turbine technology, dam design, and grid integration solutions. Although hydropower has a history of nearly 150 years, recent developments focus on improving efficiency, environmental sustainability, and integration
China Renewable Energy Certificate Market to Reach US$ 4.2 Billion by 2032; Asia-Pacific Leads with 65% Share | Key Players: China Green Certificate Trading Platform, I-REC Standard, APX Inc.
China Renewable Energy Certificate Market to Reach US$ 4.2 Billion by 2032; Asia …
Market Overview The China renewable energy certificate (REC) market reached US$ 1.2 billion in 2024 and is expected to reach US$ 4.2 billion by 2032, growing at a CAGR of 14.2% during the forecast period 2025-2032. China has been the world's largest and fastest-growing producer of renewable energy for over a decade, generating more than three times the renewable electricity of the United States. Its market share in RECs is significant
Philippines Renewable Energy Certificate Market to Reach US$ 387.45 Million by 2032; Luzon Leads with 55% Share Key Players: Philippine Renewable Energy Market, I-REC Standard, ECOHZ
Philippines Renewable Energy Certificate Market to Reach US$ 387.45 Million by 2 …
Market Overview The Philippines Renewable Energy Certificate (REC) Market reached US$ 174.93 million in 2024 and is projected to reach US$ 387.45 million by 2032, growing at a CAGR of 9.8% during the forecast period 2025-2032. The growth is driven by the country's strong commitment to renewable energy development, supported by government policies and incentives promoting clean energy adoption. The Philippines possesses abundant renewable resources, including solar, wind, hydro, and geothermal

All 5 Releases


More Releases for Neuropathic

Key Trends Reshaping the Neuropathic Pain Market: Integration Of Artificial Inte …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Neuropathic Pain Market Size Growth Forecast: What to Expect by 2025? The market valuation for neuropathic pain has experienced robust expansion lately, projected to ascend from a figure of $5.35 billion in 2024 to $5.78 billion the following year, reflecting a steady compound annual growth rate (CAGR) of 7.9%;
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others. The Neuropathic Ocular Pain market
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022 Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End. Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would